AI Science Tracker
EN

A combined deep-learning and clinical model predicts positive BI-RADS 4A mammography lesions

The Eighth Affiliated Hospital, Sun Yat-sen University · 27 Nov 2024 · medicine

Discovery

A combined deep-learning and clinical model predicts positive BI-RADS 4A mammography lesions

Source check: Source checked. Not independent scientific confirmation.

Finding: In a retrospective cohort of 590 women with BI-RADS 4A lesions and pathology results, a model combining age, nipple discharge, ultrasound BI-RADS assessment, and Mammomat AI classification had AUCs of 0.85 in training, 0.82 in internal validation, and 0.84 in an external hospital cohort of 123 patients. The selected population and retrospective design limit generalization; diagnostic performance does not establish reduced biopsies or improved clinical outcomes.

Technology: Mammomat AI v3 deep-learning image detection, segmentation and classification integrated with clinical predictors

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Mammomat AI v3 supplied mammographic classification results combined with clinical factors in the prediction model.
Test and result
The combined model was evaluated against pathology in retrospective training and internal cohorts and an external cohort from a second hospital; the reported AUCs were 0.85, 0.82, and 0.84, respectively.
Limitation / still unknown
The cohorts were retrospective and restricted to BI-RADS 4A patients; improved patient outcomes or reduced biopsy rates were not demonstrated.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://qims.amegroups.org/article/view/131550/html

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Full primary publisher article, including Methods, Results, author affiliations and publication history.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.